Loading market dashboard
Stoke Therapeutics, Inc.
STOKHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Stoke Therapeutics, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $558.31M | $231.45M - $999.43M | -$234.72M | $1.82 | 7 |
| Dec 2029 | $341.24M | $141.47M - $610.86M | -$143.46M | $0.319 | 7 |
| Dec 2028 | $126.42M | $125.36M - $127.47M | -$53.15M | -$1.949 | 8 |
| Dec 2027 | $46.23M | $33.66M - $55.55M | -$19.44M | -$3.117 | 7 |
| Dec 2026 | $26.23M | $12.00M - $43.78M | -$11.03M | -$3.222 | 8 |
| Dec 2025 | $188.80M | $185.92M - $190.78M | -$79.37M | $0.123 | 8 |
| Dec 2024 | $17.92M | $15.74M - $18.82M | -$7.53M | -$2.018 | 7 |
| Dec 2023 | $15.16M | $6.28M - $27.13M | -$6.37M | -$2.16 | 6 |
| Dec 2022 | $11.70M | $10.76M - $12.77M | -$2.34M | -$2.661 | 2 |